1 Endocrinology Department, Parc Taulí Sabadell University Hospital, Institut d'Investigacio i Innovació Parc Taulí, Autonomous University of Barcelona , Barcelona, Spain .
2 General Surgery Department, Parc Taulí Sabadell University Hospital, Institut d'Investigacio i Innovació Parc Taulí, Autonomous University of Barcelona , Barcelona, Spain .
Diabetes Technol Ther. 2018 Apr;20(4):296-302. doi: 10.1089/dia.2017.0321. Epub 2018 Feb 22.
Subcutaneous (s.c.) glucose sensors have become a key component in type 1 diabetes management. However, their usability is limited by the impact of foreign body response (FBR) on their duration, reliability, and accuracy. Our study gives the first description of human acute and subacute s.c. response to glucose sensors, showing the changes observed in the sensor surface, the inflammatory cells involved in the FBR and their relationship with sensor performance.
Twelve obese patients (seven type 2 diabetes) underwent two abdominal biopsies comprising the surrounding area where they had worn two glucose sensors: the first one inserted 7 days before and the second one 24 h before biopsy procedure. Samples were processed and studied to describe tissue changes by two independent pathologists (blind regarding sensor duration). Macrophages quantification was studied by immunohistochemistry methods in the area surrounding the sensor (CD68, CD163). Sensor surface changes were studied by scanning electron microscopy. Seven-day continuous glucose monitoring records were considered inaccurate when mean absolute relative difference was higher than 10%.
Pathologists were able to correctly classify all the biopsies regarding sensor duration. Acute response (24 h) was characterized by the presence of neutrophils while macrophages were the main cell involved in subacute inflammation. The number of macrophages around the insertion hole was higher for less accurate sensors compared with those performing more accurately (32.6 ± 14 vs. 10.6 ± 1 cells/0.01 mm; P < 0.05).
The accumulation of macrophages at the sensor-tissue interface is related with decrease in accuracy of the glucose measure.
皮下(s.c.)葡萄糖传感器已成为 1 型糖尿病管理的关键组成部分。然而,其可用性受到异物反应(FBR)对其持续时间、可靠性和准确性的影响限制。我们的研究首次描述了人体对葡萄糖传感器的急性和亚急性 s.c. 反应,显示了传感器表面观察到的变化、参与 FBR 的炎症细胞及其与传感器性能的关系。
12 名肥胖患者(7 名 2 型糖尿病患者)接受了两次腹部活检,包括他们佩戴两个葡萄糖传感器的周围区域:第一个传感器在活检前 7 天插入,第二个传感器在活检前 24 小时插入。对样本进行处理和研究,以通过两名独立的病理学家(对传感器持续时间不了解)描述组织变化。通过免疫组织化学方法研究传感器周围区域的巨噬细胞数量(CD68、CD163)。通过扫描电子显微镜研究传感器表面的变化。当平均绝对相对差异高于 10%时,将 7 天连续血糖监测记录视为不准确。
病理学家能够正确地根据传感器持续时间对所有活检进行分类。急性反应(24 小时)的特征是存在中性粒细胞,而巨噬细胞是亚急性炎症的主要细胞。与更准确的传感器相比,插入孔周围的巨噬细胞数量更多(32.6±14 与 10.6±1 个/0.01mm;P<0.05)。
传感器与组织界面处巨噬细胞的积累与血糖测量准确性的降低有关。